reference/12885549

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12885549

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study
endingPage	4505
issn	1068-9265 1534-4681
issueIdentifier	13
pageRange	4498-4505
publicationName	Annals of Surgical Oncology
startingPage	4498
bibliographicCitation	Eguchi H, Takeda Y, Takahashi H, Nakahira S, Kashiwazaki M, Shimizu J, Sakai D, Isohashi F, Nagano H, Mori M, Doki Y. A Prospective, Open-Label, Multicenter Phase 2 Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology. 2019 Aug 22;26(13):4498–505. doi: 10.1245/s10434-019-07735-8.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0c5f3b49002f1ec392a0016d2e68627 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_510c922ddd1fadcc0674721f36157393 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea4e06f7446f7052c31b17a119023a63 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1168a002e95ac0deb38abc19cd7b17d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea3e794888ee7839dc1753e3c86532b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd9a7f742b92211db7d0b47f5885c5b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0326ab3e4ec2d688a35adb9ed7d2fa4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_799fbced4da9377ba6000b0a5900697e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd356f917ca3633116408efa30ddab33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80147f12e946c0a2ce33e40818a56bd8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e06ee811c7ce51f538c356cbfae6d478
date	2019-08-22^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1245/s10434-019-07735-8 https://pubmed.ncbi.nlm.nih.gov/31440928
isPartOf	https://portal.issn.org/resource/ISSN/1534-4681 https://portal.issn.org/resource/ISSN/1068-9265 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8578
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A Prospective, Open-Label, Multicenter Phase 2 Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma
discusses	http://id.nlm.nih.gov/mesh/M0015657 http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0212066 http://id.nlm.nih.gov/mesh/M000754277 http://id.nlm.nih.gov/mesh/M0006823 http://id.nlm.nih.gov/mesh/M0008871
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D021441Q000188 http://id.nlm.nih.gov/mesh/D010190Q000532 http://id.nlm.nih.gov/mesh/D021441Q000532 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D010190Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003841Q000031 http://id.nlm.nih.gov/mesh/D005641Q000627 http://id.nlm.nih.gov/mesh/D020360 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000093542 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D057194 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D004338 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D010094Q000627 http://id.nlm.nih.gov/mesh/D010190 http://id.nlm.nih.gov/mesh/D003841Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795

Showing number of triples: 1 to 60 of 60.